Their NRG1 inhibitory antibody, 7E3, was able to promote apoptosis in the pancreatic tumour cells and CAFs, and inhibit the growth of the tumour.93 Other studies have combined different CAF-targeting and tumour-targeting drugs to investigate their dual anti-tumour efficacy. The gene discussed is NRG1; the disease is neoplasm.